270 results on '"Annaratone, Laura"'
Search Results
2. HER2 in Breast Cancer
3. PAX8–GLIS3 gene fusion is a pathognomonic genetic alteration of hyalinizing trabecular tumors of the thyroid
4. Prognostic role of PD-L1 and immune-related gene expression profiles in giant cell tumors of bone
5. Tissues under-vacuum to overcome suboptimal preservation
6. Phenotypic characterisation of immune cells associated with histological regression in cutaneous melanoma
7. Thymidylate synthase maintains the de-differentiated state of triple negative breast cancers
8. HER2 in Breast Cancer
9. HER2 in Breast Cancer
10. Current Projects in Pre-analytics: Where to Go?
11. The Pre-analytical Phase in Surgical Pathology
12. 'To Be or Not to Be in a Good Shape': Diagnostic and Clinical Value of Nuclear Shape Irregularities in Thyroid and Breast Cancer
13. RollFISH achieves robust quantification of single-molecule RNA biomarkers in paraffin-embedded tumor tissue samples
14. Critical roles of specimen type and temperature before and during fixation in the detection of phosphoproteins in breast cancer tissues
15. The Dilemma of HER2 Double-equivocal Breast Carcinomas: Genomic Profiling and Implications for Treatment
16. FOXA1 and AR in invasive breast cancer: new findings on their co-expression and impact on prognosis in ER-positive patients
17. ASPM and CITK regulate spindle orientation by affecting the dynamics of astral microtubules
18. Abstract 5418: Comprehensive genomic profiling of HER2low breast carcinomas unveils unique genomic features and actionable genetic alterations
19. Dual therapy targeting the endocannabinoid system prevents experimental diabetic nephropathy
20. Tissue Fixation with a Formic Acid-Deprived Formalin Better Preserves DNA Integrity over Time.
21. Additional file 1 of Integrative genomic and transcriptomic analyses illuminate the ontology of HER2-low breast carcinomas
22. Additional file 2 of Integrative genomic and transcriptomic analyses illuminate the ontology of HER2-low breast carcinomas
23. Unusual Patterns of HER2 Expression in Breast Cancer: Insights and Perspectives
24. Search for Neuro-Endocrine Markers (Chromogranin A, Synaptophysin and VGF) in Breast Cancers. An integrated Approach Using Immunohistochemistry and Gene Expression Profiling
25. Current Projects in Pre-analytics: Where to Go?
26. The Pre-analytical Phase in Surgical Pathology
27. Molecular Characterization of Prostate Cancers in the Precision Medicine Era
28. Characterization of Neuroendocrine Tumors of the Pancreas by Real-Time Quantitative Polymerase Chain Reaction. A Methodological Approach
29. “To Be or Not to Be in a Good Shape”: Diagnostic and Clinical Value of Nuclear Shape Irregularities in Thyroid and Breast Cancer
30. Pursuit of Gene Fusions in Daily Practice: Evidence from Real-World Data in Wild-Type and Microsatellite Instable Patients
31. Evolving concepts in HER2 evaluation in breast cancer: Heterogeneity, HER2-low carcinomas and beyond
32. Identification of novel non-coding RNA-based negative feedback regulating the expression of the oncogenic transcription factor GLI1
33. DSCAM-AS1-Driven Proliferation of Breast Cancer Cells Involves Regulation of Alternative Exon Splicing and 3’-End Usage
34. Identification of TENM4 as a Novel Cancer Stem Cell-Associated Molecule and Potential Target in Triple Negative Breast Cancer
35. Critical Steps in Tissue Processing in Histopathology
36. Osteogenic Potential of Fast Set Bioceramic Cements: Molecular and In Vitro Study
37. The Oncocytic Variant of Poorly Differentiated Thyroid Carcinoma Shows a Specific Immune-Related Gene Expression Profile
38. DSCAM-AS1-Driven Proliferation of Breast Cancer Cells Involves Regulation of Alternative Exon Splicing and 3′-End Usage
39. AR/ER Ratio Correlates with Expression of Proliferation Markers and with Distinct Subset of Breast Tumors
40. Cold Formalin Fixation Guarantees DNA Integrity in Formalin Fixed Paraffin Embedded Tissues: Premises for a Better Quality of Diagnostic and Experimental Pathology With a Specific Impact on Breast Cancer
41. The Multifaceted Nature of Tumor Microenvironment in Breast Carcinomas
42. Eccrine spiradenoma of the nipple: Case report, differential diagnosis and literature review
43. Basic principles of biobanking: from biological samples to precision medicine for patients.
44. HIF-1 activation induces doxorubicin resistance in MCF7 3-D spheroids via P-glycoprotein expression: a potential model of the chemo-resistance of invasive micropapillary carcinoma of the breast
45. Additional file 1: of FOXA1 and AR in invasive breast cancer: new findings on their co-expression and impact on prognosis in ER-positive patients
46. Paclitaxel-Loaded Nanosponges Inhibit Growth and Angiogenesis in Melanoma Cell Models
47. El impacto de la citología maligna de descarga del pezón (NDc) en el tratamiento quirúrgico de pacientes con cáncer de mama
48. The expression of LINE1-MET chimeric transcript identifies a subgroup of aggressive breast cancers
49. Primary Thymic Signet Ring Cell Adenocarcinoma: A Currently Unrecognized Variant
50. Thymidylate synthase maintains the de-differentiated state of aggressive breast cancers
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.